Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells

E7050 is a potent inhibitor of c-Met receptor tyrosine kinase and has potential for cancer therapy. However, the underlying molecular mechanism involved in the anti-cancer property of E7050 has not been fully elucidated. The main objective of this study was to investigate the anti-tumor activity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tsung-Teng, Chen, Chuan-Mu, Lan, Ying-Wei, Lin, Song-Shu, Choo, Kong-Bung, Chong, Kowit-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740914/
https://www.ncbi.nlm.nih.gov/pubmed/36499211
http://dx.doi.org/10.3390/ijms232314884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740914/
https://www.ncbi.nlm.nih.gov/pubmed/36499211
http://dx.doi.org/10.3390/ijms232314884

Ejemplares similares